Tuesday, 10th of May 2011 |
I found this article the same week that I read about Merck's donation of HPV vaccine to Rwanda, the first country in central Africa to introduce HPV on a nationwide scale. Rwanda was also the first country in central Africa to introduce pneumococcal vaccine. This is a hypothesis with legs.
‘[G]ood country-level governance is an imperative pre-requisite for the successful early introduction of new vaccines into poor African nations.’
Abstract below; full text, with figures, is at http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0013802
Good reading.
BD
Factors Affecting the Introduction of New Vaccines in Poor Countries
Abstract
Background: A major effort to introduce new vaccines into poor nations of the world was initiated in recent years with the help of the GAVI alliance. The first vaccines introduced have been the Haemophilus influenzae type B (Hib) and the hepatitis
B (Hep B) vaccines. The introduction of these vaccines during the first phase of GAVI’s operations demonstrated considerable variability. We set out to study the factors affecting the introduction of these vaccines. The African Region
(AFRO), where new vaccines were introduced to a substantial number of countries during the first phase of GAVI’s funding, was selected for this study.
Methodology/Principal Findings: GAVI-eligible AFRO countries with a population of 0.5 million or more were included in the study. Countries were analyzed and compared for new vaccine introduction, healthcare indicators, financial indicators
related to healthcare and country-level Governance Indicators, using One Way ANOVA, correlation analysis and Qualitative Comparative Analysis (QCA). Introduction of new vaccines into AFRO nations was associated primarily with high country level Governance Indicator scores. The use of individual Governance Indicator scores, as well as a combined Governance Indicator score we developed, demonstrated similar results.
Conclusions/Significance: Our study results indicate that good country-level governance is an imperative pre-requisite for the successful early introduction of new vaccines into poor African nations. Enhanced support measures may be required to effectively introduce new vaccines to countries with low governance scores. The combined governance score we developed may thus constitute a useful tool for helping philanthropic organizations make decisions regarding the type of support
needed by different countries to achieve success.
Citation: Glatman-Freedman A, Cohen M-L, Nichols KA, Porges RF, Saludes IR, et al. (2010) Factors Affecting the Introduction of New Vaccines to Poor Nations: A
Comparative Study of the Haemophilus influenzae Type B and Hepatitis B Vaccines. PLoS ONE 5(11): e13802. doi:10.1371/journal.pone.0013802
Editor: David Joseph Diemert, The George Washington University Medical Center, United States of America
Received March 23, 2010; Accepted September 24, 2010; Published November 2, 2010
Copyright: _ 2010 Glatman-Freedman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: af1200@nyu.edu
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40757856 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |